S3 expert for ASMI event
September 13, 2013
THE Australian Self-Medication
Industry this morning announced
that international ‘switch’ expert
Natalie Gauld will be one of
the presenters at its upcoming
conference in Sydney on 14 Nov.
Gauld, a pharmacist by
background, recently completed a
PhD looking at why countries vary
in prescription to non-prescription
classification (or switch) of
medicines.
She will speak on the top of
“S3 - is the Australian Consumer
Missing Out,” detailing her research
which involved in-depth interviews
with stakeholders in the US, UK,
Australia, New Zealand and Japan.
Gauld was the lead author of a
study, published last year in the Self
Care international journal, which
compared Australia, NZ and the UK,
and found that Australia led “switch
innovation” in the early 2000s but
its progressiveness has diminished
in recent years.
ASMI spokesperson Filomena
Maise said the plenary session
would deliver critical insights for
the consumer healthcare industry.
“The issue of lifting the current
restrictions on S3 communication
remains high on ASMI’s agenda and
is an issue that affects Australian
consumers, our members and the
broader healthcare community”.
ASMI is proposing a model where
the emphasis will be on creating
consumer awareness about the
condition and/or symptoms for
which a particular S3 medicine
is indicated, and highlighting the
importance of the role of the
pharmacist in determining whether
the medicine is appropriate for that
consumer.
This “S3 Communication” model
was part of ASMI’s response to
the consultation on the review of
the scheduling framework, as well
as the recent consultation on the
advertising of therapeutic goods.
CLICK HERE for conference info.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Sep 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Sep 13
